BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23135074)

  • 21. Metaglip and Avandamet for type 2 diabetes.
    Med Lett Drugs Ther; 2002 Dec; 44(1146):107-9. PubMed ID: 12500153
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of metformin-associated lactate acidosis by haemodialysis].
    Schousboe K; El Fassi D; Secher EL; Elming H; Rasmussen K; Hornum M
    Ugeskr Laeger; 2012 Jun; 174(23):1604-6. PubMed ID: 22673381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal incontinence resolved using metformin withdrawal.
    Gerstel C; Zarate Lagunes M; Vischer UM
    J Am Geriatr Soc; 2011 Apr; 59(4):756-7. PubMed ID: 21492103
    [No Abstract]   [Full Text] [Related]  

  • 24. Metformin-induced lactic acidosis: usefulness of measuring levels and therapy with high-flux haemodialysis.
    Martin Gómez MA; Sánchez Martos MD; García Marcos SA; Serrano Carrillo de Albornoz JL
    Nefrologia; 2011; 31(5):610-1. PubMed ID: 21959733
    [No Abstract]   [Full Text] [Related]  

  • 25. Is it time to test metformin in breast cancer prevention trials? A reply to the authors.
    Barba M; Muti P
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2565; author reply 2565. PubMed ID: 19745224
    [No Abstract]   [Full Text] [Related]  

  • 26. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
    Wildasin EM; Skaar DJ; Kirchain WR; Hulse M
    Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe hypoglycemia in a patient with type 2 diabetes mellitus on metformin monotherapy.
    Talwalkar PG; Deotale P
    J Assoc Physicians India; 2007 Jun; 55():458-9. PubMed ID: 17882769
    [No Abstract]   [Full Text] [Related]  

  • 28. Summaries for patients. How do older diabetes drugs compare in their effects on heart and blood vessel disease?
    Ann Intern Med; 2012 Nov; 157(9):I-28. PubMed ID: 23128878
    [No Abstract]   [Full Text] [Related]  

  • 29. [Medications for type-2 diabetes and high blood pressure].
    Schröder H
    Med Monatsschr Pharm; 2002 Nov; 25(11):386-8. PubMed ID: 12474347
    [No Abstract]   [Full Text] [Related]  

  • 30. Initial nonadherence, primary failure and therapeutic success of metformin monotherapy in clinical practice.
    Nichols GA; Conner C; Brown JB
    Curr Med Res Opin; 2010 Sep; 26(9):2127-35. PubMed ID: 20658898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does glucose infusion exacerbate metformin-associated lactate acidosis? A case report.
    Brouwers MC; Schaper N; Keeris L
    Diabetes Res Clin Pract; 2009 Jul; 85(1):e1-3. PubMed ID: 19427052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Database evaluation of the effects of long-term rosiglitazone treatment on cardiovascular outcomes in patients with type 2 diabetes.
    Loebstein R; Dushinat M; Vesterman-Landes J; Silverman B; Friedman N; Katzir I; Kurnik D; Lomnicky Y; Kokia E; Halkin H
    J Clin Pharmacol; 2011 Feb; 51(2):173-80. PubMed ID: 20484611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin use in decompensated heart failure.
    Boyd A; Nawarskas J
    Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing therapy and adverse effects with antihyperglycemic agents: a focus on metformin and acarbose.
    Phillips BB
    Pharm Pract Manag Q; 1997 Oct; 17(3):21-31. PubMed ID: 10173308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A safe and effective drug?
    Doogue MP
    N Z Med J; 2014 Oct; 127(1404):6-7. PubMed ID: 25331306
    [No Abstract]   [Full Text] [Related]  

  • 37. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.
    Medina Santillán R; Reyes-García G; Mateos-García E
    Proc West Pharmacol Soc; 2002; 45():137-8. PubMed ID: 12434558
    [No Abstract]   [Full Text] [Related]  

  • 38. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
    Sobieraj DM; Freyer CW
    Ann Pharmacother; 2010; 44(7-8):1334-7. PubMed ID: 20516361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin use in an obese diabetic patient from weeks 1 to 21 of pregnancy.
    Nagai T; Imamura M; Mori M
    J Med; 2003; 34(1-6):163-8. PubMed ID: 17682321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.